Editorial: Adjuvant chemotherapy with gemcitabine plus erlotinib vs. gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?—review of the open label phase III trial CONKO 005

wisniewski, mathilde university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France , placide, pierre-alain university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France , granier, sandra university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France , al shatti, yacoub university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France , al qalaf, shuaib university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France , bouattour, mohamed university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France , lamuraglia, michele university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France , hammel, pascal university denis diderot-paris vii - hôpital beaujon (ap-hp) - department of digestive and medical oncology, Clichy, France

2654509